您的购物车当前为空
BF-168 is a candidate probe for PET and specifically recognizes both neuritic and diffuse plaques (Ki: 6.4 nM for Aβ1-42).


为众多的药物研发团队赋能,
让新药发现更简单!
BF-168 is a candidate probe for PET and specifically recognizes both neuritic and diffuse plaques (Ki: 6.4 nM for Aβ1-42).
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 2 mg | ¥ 2,120 | 5日内发货 | |
| 5 mg | ¥ 3,160 | 5日内发货 | |
| 25 mg | ¥ 11,400 | 10-14周 | |
| 50 mg | ¥ 14,900 | 10-14周 | |
| 100 mg | ¥ 23,700 | 10-14周 |
| 产品描述 | BF-168 is a candidate probe for PET and specifically recognizes both neuritic and diffuse plaques (Ki: 6.4 nM for Aβ1-42). |
| 靶点活性 | β-Amyloid (1–42):ki: 6.4 nM |
| 体外活性 | BF-168 is a potent agent that selectively recognizes SPs and NFTs in AD brain. BF-168 is a candidate probe for PET and is found to specifically recognize both neuritic and diffuse plaques. |
| 体内活性 | Intravenous injection of BF-168 in PS1/APP and APP23 transgenic mice results in specific in vivo labeling to both compact and diffuse amyloid deposits in the brain. In addition, 18F-radiolabeled BF-168 demonstrates abundant initial brain uptake (3.9% injected dose/gm at 2 min after injection) and fast clearance (t1/2=24.7 min) after intravenous administration in normal mice. |
| 分子量 | 312.34 |
| 分子式 | C18H17FN2O2 |
| CAS No. | 634911-47-0 |
| 密度 | 1.258 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | Shipping with blue ice/Shipping at ambient temperature. |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
对于不同动物的给药剂量换算,您也可以参考 更多